P53 gene mutations are associated with shortened survival, in patients with advanced non-small cell lung cancer.

被引:0
|
作者
Murakami, I
Hiyama, K
Yamakido, M
Kasagi, F
Yokosaki, Y
机构
[1] Natl Hiroshima Hosp, Dept Internal Med, Dept Lab Med, Hiroshima, Japan
[2] Hiroshima Univ, Dept Internal Med 2, Sch Med, Hiroshima 730, Japan
[3] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:A714 / A714
页数:1
相关论文
共 50 条
  • [21] Arg72Pro P53 gene polymorphism:: Clinical relevance and relation with P53 mutations in non-small cell lung cancer (NSCLC) patients.
    Jassem, J
    Szymanowska, A
    Jassem, E
    Borg, A
    Holm, K
    Dziadziuszko, R
    Rzyman, W
    Kobierska-Gulida, G
    Limon, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 655S - 655S
  • [22] P53, FHIT, K-RAS GENE MUTATIONS ARE ASSOCIATED WITH SMOKING IN NON-SMALL CELL LUNG CANCER BY META-ANALYSIS
    Ma, L.
    Zhao, M-J
    Wang, Q. L. Xiu-Lin
    Wang, X-G
    RESPIROLOGY, 2011, 16 : 133 - 136
  • [23] Germline mutations among patients with non-small cell lung cancer.
    Yang, Tongtong
    Liu, Huanhuan
    Li, Mingwei
    Zhang, Yanrui
    Zhang, Yun
    Liang, Xiayuan
    Lou, Feng
    Cao, Shanbo
    Wang, Huina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells
    Lai, SL
    Perng, RP
    Hwang, JL
    JOURNAL OF BIOMEDICAL SCIENCE, 2000, 7 (01) : 64 - 70
  • [25] The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development
    Van Nostrand, Jeanine L.
    Brisac, Alice
    Mello, Stephano S.
    Jacobs, Suzanne B. R.
    Luong, Richard
    Attardi, Laura D.
    CANCER DISCOVERY, 2015, 5 (06) : 622 - 635
  • [26] Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
    Yoshio Tomizawa
    Takashi Kohno
    Takeshi Fujita
    Masaharu Kiyama
    Ryusei Saito
    Masayuki Noguchi
    Yoshihiro Matsuno
    Setsuo Hirohashi
    Naohito Yamaguchi
    Takashi Nakajima
    Jun Yokota
    Oncogene, 1999, 18 : 1007 - 1014
  • [27] Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
    Tomizawa, Y
    Kohno, T
    Fujita, T
    Kiyama, M
    Saito, R
    Noguchi, M
    Matsuno, Y
    Hirohashi, S
    Yamaguchi, N
    Nakajima, T
    Yokota, J
    ONCOGENE, 1999, 18 (04) : 1007 - 1014
  • [28] Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
    Cheng-long Huang
    Toshihiko Taki
    Masashi Adachi
    Takaaki Konishi
    Masahiko Higashiyama
    Masayuki Miyake
    Oncogene, 1998, 16 : 2469 - 2477
  • [29] Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
    Huang, C
    Taki, T
    Adachi, M
    Konishi, T
    Higashiyama, M
    Miyake, M
    ONCOGENE, 1998, 16 (19) : 2469 - 2477
  • [30] Radon and p53 mutations in lung cancer.
    Yngveson, A
    Williams, C
    Hjerpe, A
    Lundeberg, J
    Söderkvist, P
    Pershagen, G
    EPIDEMIOLOGY, 1999, 10 (04) : S83 - S83